Come up with a name for your new list and we'll add to it:
LeukoSight raised a round of funding on April 21, 2009. Investors include
Maryland Technology Development Corporation.
LeukoSight Inc. is an early stage biotechnology company developing a line of therapeutics that can be used to treat autoimmune and inflammatory diseases.…